NASDAQ: SPRY
Recent developments with ARS Pharmaceuticals Inc (SPRY) have led to the company’s beta value being reach 0.78 cents.
On Monday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) was -4.53% drop from the session before settling in for the closing price ...
$2.17M in average volume shows that ARS Pharmaceuticals Inc (SPRY) is heading in the right direction
ARS Pharmaceuticals Inc (NASDAQ: SPRY) kicked off on Monday, up 8.29% from the previous trading day, before settling in for ...
Let’s look at the key reasons that are pushing ARS Pharmaceuticals Inc (SPRY) to new highs
ARS Pharmaceuticals Inc (NASDAQ: SPRY) on Friday, plunged -8.73% from the previous trading day, before settling in for the closing ...
ARS Pharmaceuticals Inc (SPRY) latest performance of 5.14% is not what was on cards
ARS Pharmaceuticals Inc (NASDAQ: SPRY) started the day on Wednesday, with a price increase of 5.14% at $10.44, before settling ...
Now that ARS Pharmaceuticals Inc’s volume has hit 3.03 million, investors get a glimpse of its size.
On Monday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) opened lower -10.84% from the last session, before settling in for the closing ...
ARS Pharmaceuticals Inc (SPRY) average volume reaches $2.50M: Are the Stars Lining Up for Investors?
ARS Pharmaceuticals Inc (NASDAQ: SPRY) open the trading on Thursday, with a bit cautious approach as it glided -9.45% to ...
